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Crosstalk between cancer cells and carcinoma-associated fibroblasts (CAFs) has earned recognition as an
interaction that plays a pivotal role in carcinogenesis. Thus, we attempted to clarify whether increase in the level of
CAFs promotes cancer progression by proportionally enhancing the interaction between cancer cells and CAFs.
We first analyzed clinical correlation between the levels of fibroblasts and cancer progression and found that the
level of CAFs made a noticeable difference on the prognosis of patients with oral squamous cell carcinoma
(OSCC). In vivo animal study also demonstrated that tumor volume depended on the dose of CAFs that was co-
injected with OSCC cells. The same tendency was observed in an in vitro study. We also found that interleukin-1α
(IL-1α) secreted from OSCC cells had dual effects on CAFs: IL-1α not only promoted the proliferation of CAFs but
also upregulated the secretion of cytokines in CAFs such as CCL7, CXCL1, and IL-8. The induction activity of
cytokine secretion by IL-1α surpassed that of proliferation in OSCC cells. In summary, we unraveled an important
interactive mechanism of carcinogenesis: IL-1α released from carcinoma stimulates the proliferation of CAFs and
the simultaneous increase in cytokine secretion from CAFs promotes cancer progression in human OSCC. On the
basis of these findings, we propose that the level of CAFs is eligible for being selected as a prognostic factor that
will be useful in routine diagnosis. We also propose that blockage of reciprocal interaction between cancer cells
and CAFs will provide an insight for developing novel chemotherapeutic strategy.
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Accumulating evidence suggests that cancer treatment targeting
cancer cells alone is insufficient to completely remove cancer because
cancer progression is governed by a complex microenvironment
composed of fibroblasts and their soluble factors, extracellular matrix,
various immune competent cells and their soluble factors, and
angiogenic factors [1–3]. Thus, it is widely acknowledged that tumor
microenvironment is a significant contributor to cancer initiation and
progression [4–6].
Carcinoma-associated fibroblasts (CAFs) have emerged as one of
the most important components of tumor microenvironment that
plays an active role in carcinogenesis [7–9]. Fibroblasts adjacent to
transformed epithelial cells were reported to have modified
characteristics compared to fibroblasts in normal stroma [10].
While the nature of CAFs has not been clearly identified as yet,
CAFs are known to have characteristics of myofibroblasts [11,12]. It
is also widely recognized that CAFs are composed of increasedfraction of senescent cells along with decreased fraction of
proliferative cells [13]. However, the histologic observations of
human cancer that the level of fibrosis supporting cancer cells was
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reported [14–16].
The interaction between cancer cells and CAFs has been
investigated as a main carcinogenic mechanism. As communication
tools between cancer cells and CAFs, CAF-derived growth factors and
their receptors have been studied. Up to date, diverse growth factors
and their cognate receptors derived from cancer cells or CAFs have
been reported in several human cancers [17–19]. Because the
interaction between cancer cells and CAFs is considered to be an
intercellular dialogue, cytokines and chemokines have been investi-
gated as another communication tool. Co-culture of cancer cells with
CAFs induced the production of cytokines such as interleukin-1α
(IL-1α), IL-6, IL-8, vascular endothelial growth factor A, CCL20,
and cyclooxygenase 2. As cancer cell–associated IL-1α could bind to
IL-1R1 expressed predominantly in CAFs to increase the production
of cytokines listed above, it was established as the major initiator of
enhanced cytokine production in CAFs [20,21]. Our previous study
also found that a reciprocal interaction between oral squamous cell
carcinoma (OSCC) cells and CAFs promoted cancer invasion: IL-1α
released from OSCC cells stimulated CAFs to secrete CCL7, CXCL1,
and IL-8, thereby facilitating cancer invasion [22].
Desmoplasia refers to the growth of dense connective tissue or
stroma [23]. Because desmoplasia is a typical sign of wound healing
and cancer progression, it has been focused on as a potentially
effective prognostic factor for survival. Nevertheless, previous studies
have been carried out using whole stroma around cancer rather than
focusing on a specific component of stroma such as CAFs [23–25]. As
the evidence that a large portion of stroma around cancer comprises
myofibroblasts accumulates [12,26], enrichment of CAFs in the
cancer-associated stroma has been spotlighted as a potentially useful
indicator for cancer prognosis in recent studies [27,28]. A close
relationship between CAFs and cancer progression has been found
[8,9,16], but complete understanding of the underlying carcinogenic
mechanism remains elusive.
We believed that a study on relational mechanism between the
level of CAFs and cancer cells would contribute to the more
accurate assessment of cancer prognosis and development of a new
therapeutic strategy. Therefore, this study attempted to clarify
whether proportional increase in the number of CAFs correspond-
ingly promotes interactive response between cancer cells and CAFs
during carcinogenesis. We revealed reciprocal interaction between
cancer cells and CAFs that IL-1α released from cancer cells
stimulated the proliferation of CAFs and the simultaneous increase
in cytokine secretion from CAFs. In turn, a proportional increase
in the cytokine secretion from CAFs promoted cancer progression
in OSCC.
Materials and Methods
Patient Selection
We selected 100 patients who experienced OSCC and were
diagnosed by Yonsei Dental Hospital from 1995 to 2007. The
following data were available from the patients: age, degree of
differentiation, TNM stage, locoregional/distant recurrence, and
overall survival period. Overall survival was calculated from the date
of initial surgery to the date of death. The last date of examination was
April 30, 2011. All procedures were approved by the Institutional
Review Board of Yonsei University College of Dentistry (IRB 2-
2012-0041) in advance.Histomorphometry
To calculate stromal proportion, three tissue sections containing
both tumor and stromal portion were randomly selected from each of
the 100 patients with OSCC. Hematoxylin and eosin (H&E)–stained
tissue sections were observed to measure the stromal area.
Immunohistochemical staining using anti–α-smooth muscle actin
antibody (α-SMA, 1:100, human monoclonal; Dako, Glostrup,
Denmark) was also carried out to examine the presence of
myofibroblasts. Moreover, IL-1α antibody (1:50, rabbit polyclonal;
Abcam, Cambridge, UK) was employed to assess the relationship
between IL-1α expression and desmoplasia. Details about immuno-
histochemistry procedures are described in the Supplementary
Materials and Methods.
Image-Pro plus V 3.0 software was employed to determine the target
area. Bone, tooth, muscle, salivary gland, and fat tissues were excluded
from the measurement of stromal area. The stromal portion was
calculated as the ratio of whole stromal area to whole tumoral area (low
b 1.0 vs high ≥ 1.0). Proportion of α-SMA–expressing myofibroblasts
was examined in three randomly selected fields per slide and calculated
as the ratio of α-SMA–positive area to whole area. Because the mean
value ofα-SMA–positive proportion was 22.97%, we selected the value
as a cutoff criterion for distinguishing between low and high α-SMA
expression. For examining the expression level of IL-1α, the weighted
histoscore method was employed in this study [29].
Cell Culture
Three kinds of CAFs (CAFs 1-3) and four kinds of OSCC cell lines
(YD-10B, YD-32, YD-38, and HSC-2) were used for this study.
Three kinds of normal fibroblasts (NFs 1-3) were also used as
controls. Details about the procedures of cell culture and identifica-
tion are described in the Supplementary Materials and Methods.
Chemokines and Antibodies
Human recombinant protein CCL7 (FIC/MCP-3), human
recombinant protein CXCL1 (FSP/GRO1), human recombinant
protein IL-8 (CXCL8/GCP-1), and human recombinant protein
IL-1α (IL-1A/IL-1F1) were products of R&D Systems. Anti-human
CCL7, anti-human CXCL1, anti-human IL-8, anti-human IL-1α,
and isotype control antibodies (mouse IgG1, IgG2A, and IgG2B) were
also products of R&D Systems, Minneapolis, MN.Mouse Orthotopic Xenograft Model
Animal studies were approved by the Animal Ethics Committee of
Yonsei University College of Dentistry. BALB/c male mice (16 ± 2 g, 4
weeks of age) were provided by Central Lab Animal, Inc. (Seoul, South
Korea) Animal studies were performed with six different experimental
groups, and each group consisted of five mice. As a negative control
(Media), the cell culture medium was injected alone. Groups of cells
composed of different OSCC-to-CAF ratios were injected into the
dorsal tongue as follows: in groupCAFs, 5 × 104 CAFs were injected; in
group OSCC, 5 × 104 HSC-2 were injected; in groups OSCC:CAFs/
1:1, OSCC:CAFs/1:2, and OSCC:CAFs/1:3, 5 × 104 HSC-2 were
injected with the corresponding numbers of CAFs. After 4 weeks, the
mice were sacrificed and the dorsal tongues of mice were stained with
H&E for morphologic analysis. Tumor volume of OSCC was assessed
by two-dimensional measurements [30].
For analyzing the proliferative activity of xenografted tumor tissues,
proliferating cell nuclear antigen (PCNA) was employed. PCNA
index was accomplished for quantitative analysis by counting PCNA-
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and calculating the percentage of PCNA-positive cells. Human
vimentin was also immunostained to assess the level of human
myofibroblasts that remained in the stroma of mouse OSCC
specimens. Human vimentin–positive cells were counted in five
randomly selected microscopic fields and the percentage of vimentin-
positive cells was calculated. Result for each sample was obtained by
averaging the data from three different persons.
Cell Proliferation Assay
Cell proliferation was determined by using 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay [31]. In
monoculture system, CAFs or OSCC cells (5 × 104 per well) were
seeded and incubated overnight before treatment. Cells were treated
with either recombinant proteins or neutralizing antibodies and
subjected to MTT assay after 48 hours (OSCC cells) or 1 week
(CAFs). In co-culture system, transwell system was used to examine
the proliferation of CAFs or OSCC cells; 5 × 104 of either CAFs or
OSCC cells were seeded per well. In transwell system, cells that need to
be measured were placed in the lower chamber. That is, 5 × 104
OSCC cells were placed in the lower chamber for counting OSCC
cells, while multiples of OSCC cells or CAFs were placed in the upper
chamber, as shown in Figure 3A; 5 × 104 CAFs were seeded in the
lower chamber for counting CAFs, as shown in Figure 4C, 4D. After
incubation, only the cells in the lower chamber were used for theMTT
assay.
Transwell Invasion Assay
Membrane invasion culture system (Corning, Tewksbury, MA)
was used to quantify invasive activity as previously described [32].
CAFs or OSCC cells (2 × 104 for standard protocol and OSCC:
OSCC or CAFs/1:1, 4 × 104 for OSCC:OSCC or CAFs/1:2, and 6 ×
104 for OSCC:OSCC or CAFs/1:3) were seeded on the lower
chamber; 2 × 104 OSCC cells were placed in the upper chamber of
the transwell. After 48 hours of incubation, the cells that penetrated
the upper filter were counted manually using a light microscope.
Enzyme-Linked Immunosorbent Assay
Cells were incubated under various culture conditions and the
conditioned media were harvested after 48 hours. Concentration of
cytokines (CCL7, CXCL1, IL-8, and IL-1α) was evaluated by ELISA
according to the manufacturer’s protocol (R&D Systems).
Reverse Transcription–Polymerase Chain Reaction
Reverse transcription–polymerase chain reaction (RT-PCR) was
employed to examine mRNA expression of IL-1α in YD-10B,
YD-32, YD-38, and HSC-2 cells. Details of the RT-PCR procedure
are described in the Supplementary Materials and Methods.
Statistical Analysis
Kaplan-Meier method was employed to estimate the overall
survival of patients with OSCC. Analysis of Pearson correlation was
employed to assess the correlation between the staining data of H&E
and the staining data of α-SMA in 100 patients with OSCC. IL-1α
expression in each group was compared by the χ2 test. All variables of
the in vitro study were tested in three independent experiments, and
each experiment was performed in triplicate. The results are reported
as mean ± SD. Mann-Whitney U test was performed to analyze
differences between groups. The value of P b .05 was considered
statistically significant.Results
Overall Survival Period of Patients with OSCC Is Inversely
Correlated with the Levels of Stromal Proportion and
α-SMA Expression
Selected examples of microscopical field from stroma-rich and
stroma-poor tumors for quantification of tumor-to-stroma ratio are
shown in Figure 1A (upper panel). Histologic staining with H&E
allowed a clear-cut discrimination between stromal and epithelial
components. Of 100 patients with OSCC, 49 patients were found to
have low stromal proportion, while 51 patients were found to have
high stromal portion. From the results of survival analysis, we
observed that the survival rate of patients with OSCC was closely
associated with the stromal proportion. Patients who had rich stromal
areas showed poor survival rate in Kaplan-Meier analysis (P b .05;
Figure 1Bi). We also evaluated myofibroblast composition of OSCC
tissues by performing histomorphometry with α-SMA (Figure 1A,
lower panel). In a preliminary study, we first examined the expression
of three proteins, α-SMA, vimentin, and fibroblast activation protein,
that are widely recognized as markers of CAFs. Because α-SMA is the
most distinguishable marker of CAFs (Figure W1A), we used α-SMA
as the marker of CAFs. Results of α-SMA expression corresponded
with those of stroma in that overall survival of patients with high level
of α-SMA expression was significantly decreased compared to that of
patients with low level of α-SMA expression (P b .05; Figure 1Bii).
These results suggested that the overall survival period of patients
with OSCC correlated negatively with the levels of stromal
proportion and α-SMA expression. We also examined the correlation
between the staining data of H&E and the staining data of α-SMA in
100 patients with OSCC. Expression level of α-SMA was directly
proportional to stromal proportion (P b .05; Figure W2).Tumor Progression Depends on the Dose of Co-injected CAFs
In Vivo
To examine the effect of CAFs on cancer progression in vivo, CAFs
were co-injected with OSCC cells into the dorsal tongues of nude
mice at different doses. One mouse in group OSCC:CAFs/1:3 did
not wake up after the injection of the anesthetic. Because two mice in
group OSCC:CAFs/1:2 died during the experiment due to the
development of obstructive tongue mass, necropsies were performed
on them. After 4 weeks, no observable tumor growth (0%) was
noticed in group Media and group CAFs. Four of five mice (80%) in
group OSCC showed tumor formation. Tumors developed in all of
the mice (100%) in group OSCC:CAFs/1:1, group OSCC:CAFs/
1:2, and group OSCC:CAFs/1:3 (Figure W3A). Tumors from the co-
injected groups showed more than 16-fold increase in volume
compared to those from group OSCC in which mice were injected
with OSCC cells alone (group OSCC:CAFs/1:1: P b .01, group
OSCC:CAFs/1:2: P b .01, and group OSCC:CAFs/1:3: P b .05).
Tumor volume derived from OSCC cells was increased in accordance
with the dose of co-injected CAFs (Figure 2A).
Mouse OSCC tissues were stained with human vimentin to
exclude the voluminal effect of injected CAFs. Human vimentin was
not found in the OSCC cell mono-injected group. Human vimentin–
positive cells were detected in less than 2% of all the CAF-injected
groups and the intergroup difference was not statistically significant
(Figure W3B), suggesting that the increased tumor volume by higher
doses of co-injected CAFs was not due to higher volume of the
remaining CAFs.
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Figure 1. Overall survival period of patients with OSCC. (A) Two histologic sections of OSCC, stained with H&E (upper) and α-SMA (lower)
(C, cancer region; S, stromal region). Each column is representative of low-level stromal proportion/α-SMA expression (left) and high-level
stromal proportion/α-SMA expression (right) (original magnification, ×40; scale bar, 200 μm). Higher magnification (×200) views of
cancer and stromal regions are presented in the inset micrograph. The micrographs shown in this figure are representative of 100
independent tissues that showed similar results. (B) Overall survival of 100 patients with OSCC classified into (i) low (blue)/high (green)
stromal proportion and (ii) low (blue)/high (green) α-SMA expression was analyzed by Kaplan-Meier method.
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CAFs, and the PCNA indices of co-injected groups were significantly
higher compared with that of the OSCC mono-injected group [group
OSCC: 5.31%, group OSCC:CAFs/1:1: 13.83% (P b .01), group
OSCC:CAFs/1:2: 17.5% (P b .01), and group OSCC:CAFs/1:3:
31.43% (P b .001); Figure 2B]. These results agreed well with those
of tumor volume, indicating that the co-injected CAFs act in a dose-
dependent manner to promote the tumor progression induced by
OSCC cells in vivo.
CAFs Co-cultured with OSCC Cells Increase the Proliferation
and Invasiveness of OSCC Cells in a Dose-Dependent Manner
Cell proliferation assay showed that CAFs stimulated the prolifer-
ation of OSCC cells. As a control, OSCC cells were monoculturedwithout any treatment. Proliferation rate of OSCC cells co-cultured
with CAFs was significantly higher than that of control (OSCC:CAFs/
1:1: P b .01, OSCC:CAFs/1:2: P b .001, and OSCC:CAFs/1:3:
P b .001). Additionally, OSCC cells were co-cultured with OSCC cells
in conditions identical to CAF co-culture to confirm our assumption
that the crosstalk betweenOSCC cells andCAFs is a unique interaction.
No significant difference was found between the co-cultured groups
that consisted only of OSCC cells and the control. Proliferation rate of
OSCC cells co-cultured with CAFs was at least twice higher than that of
OSCC cells co-cultured withOSCC cells under the same doses (P b .05
for all comparisons; Figure 3A).
To study the effects of CAFs on invasion of OSCC cells, we employed
a modified transwell invasion assay. Under the same doses, the
invasiveness of OSCC cells co-cultured with CAFs was at least seven
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(Pb .01 for all comparisons). Invasiveness ofOSCCcells co-culturedwith
CAFs was increased in proportion to the dose of co-cultured CAFs, while
the invasiveness of OSCC cells co-cultured with OSCC cells was not
affected by the dose of co-cultured OSCC cells (Figure 3B).
We also investigated the effect of NFs on cell proliferation and
invasion of OSCC cells in comparison with the effect of CAFs. Even
though cell proliferation and invasiveness of OSCC cells co-cultured
with NFs were slightly increased compared to monocultured OSCC
cells or OSCC cells co-cultured with OSCC cells, a significant
difference was not found. However, cell proliferation and invasiveness
of OSCC cells co-cultured with CAFs were significantly increased
compared to OSCC cells co-cultured with NFs and other controls
(P b .05; Figure W4). These results suggested that CAFs induced the
proliferation and invasion of OSCC cells through unique interaction
with OSCC cells.Proliferation Rate of CAFs Depends on the Level of IL-1α
On the basis of the report that IL-1α secreted from OSCC
stimulates CAFs for cancer progression [22], we examined whether
IL-1α regulates the proliferation of CAFs in OSCC. First, we
screened for IL-1α expression in several human OSCC cell lines
(YD-10B, YD-32, YD-38, and HSC-2). mRNA (Figure 4, Ai and
Aii) and secreted protein (Figure 4Aiii) of IL-1α were detected in all
of the OSCC cell lines. Among the OSCC cell lines we examined,
YD-10B showed the highest IL-1α, while YD-32 showed the lowest
expression in both assays (Figure 4A). We also screened for expression
of IL-1β, another type of IL-1, in several human OSCC cell lines.
Secreted protein of IL-1β was not detected in any human OSCC cell
lines subjected to this study (data not shown). Because this study
emphasized reciprocal reaction between cancer cells and CAFs
regulated by cytokines, we focused on the role of IL-1α during
carcinogenesis. Western blot analysis was also employed to investigate
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Figure 3. Proliferation and invasiveness of OSCC cells under various co-culture conditions. OSCC cells were co-cultured with either OSCC
cells or CAFs at different doses. (A) Microscopic morphology was obtained (original magnification, ×100; scale bar, 500 μm), and cell
proliferation rate after 48 hours was determined by theMTT assay. (B) Invasion assay was performed under various co-culture conditions.
After incubation at 37°C for 48 hours, microscopic morphology was obtained (original magnification, ×100; scale bar, 100 μm) and cells
that penetrated the upper filter were counted manually under a light microscope. The micrographs shown in this figure are representative
of three independent experiments that showed similar results. Quantitative results indicate average values of three independent
experiments, each of which was conducted in triplicate (n= 9). The results are shown as mean values ± SD (n= 9) and were analyzed by
the Mann-Whitney U test (*P b .05 and **P b .01).
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all three CAFs. CAFs co-cultured with OSCC cells showed even
higher expression of IL-1R1 than monocultured CAFs (P b .05;
Figure W5A). To evaluate whether IL-1α induces the proliferation of
CAFs, CAFs were monocultured with different doses (0, 10, 100, and
1000 pg/ml) of human recombinant IL-1α protein and the
proliferation rate was measured. The proliferation rate of CAFs was
significantly increased compared to non-treated control in proportionto the dose of IL-1α (P b .01 for all comparisons; Figure 4B).
Subsequently, the proliferation rate of co-cultured CAFs with or without
the treatment of IL-1α neutralizing antibody was examined. Neutral-
izing concentration (1 μg/ml) was determined on the basis of 50%
neutralizing dose (ND50) listed in the data sheet. Proliferation rate of
CAFs co-cultured with YD-10B was significantly (P b .05) higher than
that of monocultured CAFs, but the treatment with IL-1α neutralizing
antibody resulted in marked (P b .05) reduction of proliferation rate
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found between the CAFs co-cultured with YD-10B and other control
groups treated with control antibody or human recombinant IL-1α
protein (Figure 4C). Through CAF-OSCC co-culture experiments,
we could once again confirm that IL-1α induces the proliferation of
CAFs. CAFs were co-cultured with YD-10B and YD-32, respectively.
Proliferation rate of CAFs co-cultured with YD-10B was significantly
higher than that of monocultured CAFs and CAFs co-cultured with
YD-32 (P b .05 for both comparisons). Additionally, statistical
significance was not found between the proliferation rate of mono-
cultured CAFs and CAFs co-cultured with YD-32 (Figure 4D). Taken
together, our results suggest that the proliferation of CAFs is affected by
the level of IL-1α released from the carcinoma cells.
To confirm these results in human OSCC tissues, we first
examined the histologic features of the surgical specimens of two cell
lines, YD-10B and YD-32. The level of CAFs was parallel to the level
of IL-1α of each cell line (Figure W5B). Further, we examined the
relationship between IL-1α expression and desmoplasia in 100
human OSCC surgical specimen slides. Membrane and cytoplasmic
expressions of IL-1α were frequently detected in fibroblasts from
OSCC tissue samples as well as in carcinoma cells. IL-1α expression
in human OSCC tissues was closely associated with the level of
desmoplasia, supporting in vitro data (P b .05; Figure 4E). However,
no statistical correlation was found between IL-1α expression in
cancer tissue and overall survival period (data not shown).0
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Figure 5. Cytokine secretion from CAFs under various IL-1α
expression conditions. (A) Cytokine secretions from CAFs that
were treated with or without 50 pg/ml IL-1α human recombinant
protein. (B) Cytokine secretions from CAFs that were treated with
or without 1 μg/ml neutralizing antibody against IL-1α. Mouse IgG2A
was used as a control. (C) Secretion levels of cytokines from CAFs
co-cultured with YD-10B or YD-32. Monocultured CAFs was used
as a control. In all the experiments, ELISA was employed to
measure the secretion levels of three cytokines (CCL7, CXCL1, and
IL-8) in conditioned media after 48 hours. Quantitative results
indicate average values of three independent experiments, each of
which was conducted in triplicate (n= 9). The results are shown as
mean values ± SD (n= 9) and were analyzed by the Mann-Whitney
U test (*P b .05 and ***P b .001).Cytokine Secretion from CAFs Depends on the Level of IL-1α
In our previous study, gene expression profiles of monocultured
and co-cultured CAFs were analyzed by microarray and complete data
were deposited in the Gene Expression Omnibus (Accession No.
GSE18532) [22]. On the basis of the microarray data, five cytokines
that were most upregulated in co-cultured CAFs compared to
monocultured CAFs were selected and then the top three, CCL7,
CXCL1, and IL-8, were singled out by real-time PCR.
We first examined the secretion level of three cytokines from CAFs
stimulated by OSCC cells. All three cytokines were rarely detected in
the supernatants of monocultured CAFs and co-cultured groups that
consisted only of OSCC cells. However, CCL7, CXCL1, and IL-8
were detected at high levels in the supernatants of CAFs co-cultured
with OSCC cells (Figure W6, A–C). We confirmed that an increase
in cytokine secretion also occurs through the unique interaction
between CAFs and OSCC.
To examine the direct effect of IL-1α on the secretion level of these
three cytokines from CAFs, monocultured CAFs were treated with
human recombinant IL-1α protein. Treatment concentration of
human recombinant IL-1α protein was 50 pg/ml, where 50 pg/ml
was an approximate concentration released from OSCC cells in our
study (Figure 4Aiii). While the secretion of CCL7, CXCL1, and IL-8
was almost undetectable in the non-treated CAFs, the secretion of
these three cytokines was significantly upregulated in CAFs after
IL-1α treatment (CCL7 and CXCL1: P b .001 and IL-8: P b .05;
Figure 5A). To confirm cytokine secretion from CAFs on blocking
IL-1α secreted from OSCC cells, neutralizing antibody against IL-1α
(1 μg/ml) was added to the serum-free conditioned medium of CAFs
co-cultured with OSCC cells. Treatment with IL-1α neutralizing
antibody to conditioned medium of CAFs–YD-10B co-culture
resulted in marked (P b .05 for all comparisons) reduction of
CCL7, CXCL1, and IL-8 secretion (CCL7: 94%, CXCL1: 89%, and
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Figure 6. Effect of cytokines on proliferation of OSCC cells in several
human OSCC cell lines. (A) Proliferation of OSCC cells in several
human OSCC cell lines (YD-10B, YD-32, YD-38, and HSC-2) was
measured after treatment with or without CCL7 human recombinant
protein at different doses (0, 1, 10, and 100 ng/ml). (B) Proliferation of
OSCC cells in several humanOSCC cell lines (YD-10B, YD-32, YD-38,
and HSC-2) was measured after treatment with or without
CXCL1 human recombinant protein at different doses (0, 1, 10, and
100 ng/ml). (C) Proliferation of OSCC cells in several human OSCC
cell lines (YD-10B, YD-32, YD-38, and HSC-2) was measured after
treatment with or without IL-8 human recombinant protein at
different doses (0, 1, 10, and 100 ng/ml). After incubation at 37°C
for 48 hours, the rate of cell proliferationwas determined by theMTT
assay. Non-treated cells of each cell line were used as controls.
Quantitative results indicate average values of three independent
experiments, each of which was conducted in triplicate (n = 9). The
results are shown asmean values±SD (n= 9) andwere analyzed by
the Mann-Whitney U test (*P b .05 and **P b .01).
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controls treated with isotype antibody (Figure 5B). As shown in
Figure 4A, it was confirmed that IL-1α expression was the highest in
YD-10B and the lowest in YD-32. To test whether the cytokine
secretion from CAFs is regulated by IL-1α expression in OSCC, we
compared the secretion levels of three cytokines (CCL7, CXCL1, and
IL-8) in CAFs co-cultured with each of the two OSCC cell lines
mentioned above. Secretion of the three cytokines was rarely detected
in monocultured CAFs and CAFs co-cultured with YD-32. However,
secretion of all three cytokines was significantly increased in CAFs co-
cultured with YD-10B (P b .05 for all comparisons). Cytokine
secretion levels in CAFs co-cultured with YD-10B were elevated from
21-fold (CCL7) to 165-fold (CXCL1) compared with the CAFs co-
cultured with YD-32 (Figure 5C). Thus, a conclusion could be drawn
that IL-1α stimulated cytokine secretion from CAFs.
Cytokines Secreted fromCAFs Induce Proliferation of CancerCell
We then studied whether the cytokines secreted from CAFs
induced the proliferation of OSCC cells. To evaluate whether three
cytokines from CAFs induces the proliferation of OSCC cells in
several human OSCC cell lines (YD-10B, YD-32, YD-38, and HSC-
2), OSCC cells were monocultured with different doses (0, 1, 10, and
100 ng/ml) of human recombinant protein of each cytokine and the
proliferation rate was measured. Treatment doses of cytokines were
determined on the basis of the secretion level of three cytokines from
co-cultured CAFs (CCL7: 2.6-7.0 ng/ml, CXCL1: 34.4-60.3 ng/ml,
IL-8: 15.5-32.3 ng/ml; Figure W6, A–C). The proliferation rate of all
OSCC cell lines treated with each cytokine was significantly increased
compared to non-treated control in proportion to the dose of
cytokines (Figure 6, A–C). Our results suggest that the proliferation
of OSCC cells is affected by the cytokines secreted from CAFs.
Discussion
The interaction between cancer cells and stromal fibroblasts plays a
critical role in carcinogenesis [17–22]. In this study, fibroblasts that
were adapted to tumor microenvironment were denominated as
CAFs. Identity of CAFs was verified with the expression of α-SMA
and vimentin, which are recognized asmarkers of CAFs (FigureW1B).
In light of the previous investigations that the growth of dense
connective tissue or stroma stimulates cancer progression [14–16], we
first resorted to clinical evaluation to confirm that the level of CAFs
could serve as an important criterion for predicting cancer prognosis
in this study. On the basis of the correlation data that stromal
proportion was directly proportional to expression level of α-SMA,
we suggested that CAFs are the primary contributors to stromal
component. Results of an animal study also revealed the increase of
tumor volume paralleled to the level of CAFs. To rule out voluminal
effect by co-injected CAFs, we examined human fibroblasts in
xenografted tumor mass and found no significant difference of
retained human fibroblasts among experimental groups. Given the
data that normal human fibroblasts showed no transplantability, we
could extrapolate that the co-injected CAFs could not survive while
cancer cells were colonized in mouse tongue tissue [33]. While the
proliferation of CAFs turned out to be correlated with cancer
progression, its carcinogenic factor is not unveiled. Thus, a detailed
study was carried out to examine the specific factor that underlies
CAF-mediated cancer progression.
Results of the co-culture in vitro study showed that the increased
ratio of CAFs induced the proliferation and invasiveness of OSCCcells in a dose-dependent manner. However, there was no noticeable
difference in cell proliferation and invasiveness of OSCC cells co-
cultured with NFs or co-cultured groups that consisted only of
OSCC cells, indicating that tumor-stromal crosstalk can be
Neoplasia Vol. 16, No. 11, 2014 Reciprocal Interaction through Interleukin 1α Bae et al. 937considered to be a peculiar interaction. We also found that CAFs were
stronger inducers of cell proliferation and invasion in OSCC cells
than NFs.
Prior studies, including ours, demonstrated that IL-1α is a
regulator of cytokine secretion in CAFs [20–22]. To study a direct
relationship between the level of IL-1α expression in OSCC and the
level of CAFs, we examined the effects of IL-1α expression on the
proliferation of CAFs that can serve as a contributing factor to the
proliferation of CAFs. Exposure to recombinant IL-1α protein or
treatment with IL-1α neutralizing antibody led to considerable
changes in the proliferation of CAFs. For further clinical verification
of our results, we examined IL-1α expression in OSCC tissue
samples. Boundary area between OSCC and stroma stained strongly
with IL-1α in immunohistochemistry. Another recent study also
reported that a regulatory factor of reciprocal interaction between
cancer and stroma was strongly immunostained in the stromal region
proximal to cancer epithelium [34]. IL-1α expression in human
OSCC tissues was strongly associated with the level of CAFs. Our
findings in the in vitro study was also supported by the results of
histomorphometry that histologic feature of surgical tissue in YD-10B
cell line showed invasive squamous cell carcinoma with abundant
stromal reaction, whereas the surgical specimen of YD-32 cell line
revealed scanty stromal reaction. Therefore, it could be concluded
that IL-1α plays an important role in cancer progression by mediating
the crosstalk between tumor and stroma. We presumed that IL-1R1
expression of CAFs co-cultured with OSCC cells would be increased
when CAFs take IL-1α signal from OSCC cells. Expression level of
IL-1R1 was increased substantially when CAFs are co-cultured with
OSCC cells. The results suggest that CAFs are responsive to IL-1α
released from OSCC cells. Further study silencing IL-1α receptor on
CAFs and seeing downstream inhibition of cytokine production
would be helpful to clarify unrevealed mechanism underlying the
interaction between carcinoma and CAFs.
Our previous study showed that remarkable changes were found in
cytokine expressions of CAFs when they were exposed to cancer cells
[22]. In this study, we reconfirmed that an increase in cytokine
secretion occurs through the unique interaction between CAFs
and OSCC.
All results of cell proliferation assay in this study showed that
proliferation rate of CAFs were not increased more than three times
under various experimental conditions. However, the effect of CAFs
including tumor volume, invasive activity, and induction of cytokines
was more powerful at least 7 times or even up to 165 times. The
secretion level of cytokines was gradually in direct proportion to the
level of CAFs (Figure W6, A–C). Thus, a conclusion could be drawn
that CAFs contribute extensively to cancer progression beyond only
mere proliferative effect.
CAFs are known to have characteristics of senescent cells [13].
Thus, senescence-associated secretory phenotype factors of senescent
cells can render the tissue microenvironment favorable for cancer
progression [35,36]. Given our data that the induction activity for
cytokine secretion through IL-1α (more than 47-fold increase)
surpassed the induction activity for cell proliferation of CAFs (less than
three times increase), we could presume that a certain fraction of CAFs
is obliged to undergo a senescent process. Taken together, a further
study would be needed to clarify whether both proliferative CAFs and
senescent CAFs harboring different distribution of receptors differ-
ently responded to IL-1α coexist in tumor microenvironment or one
type of CAFs merely shows sequential response to IL-1α.We then evaluated whether these cytokines released from CAFs
stimulated by IL-1α might induce proliferation of OSCC cells. All
three cytokines induced proliferation of OSCC cells, confirming that
cytokines secreted from CAFs are immediate causes of tumor growth.
Our findings are supported by previous studies that CXCL1 and IL-8
stimulated the proliferation of cancer cells. CXCL1 was reported to
modulate tumor growth and proliferation of cancer cells [37,38]. A
close relationship between IL-8 and proliferation of cancer cells has
been found in several human cancers including OSCC [39–41].
CCL7 also induced the proliferation of cancer cells; however, the
induction activity of invasion surpassed proliferative activity [22]. We
further suggest that other regulatory factors might also be responsible
for the increased tumor cell proliferation because an increase in tumor
volume that paralleled the higher proportion of CAFs in co-culture
(more than 16-fold increase) was more definitely changed than
proliferation of OSCC cells treated with these cytokines (less than
2.5-fold increase). For example, CXCL2 (growth-regulated oncogene
2 (GRO2)/GROβ) and CXCL3 (GRO3/GROγ) might be involved
in the proliferation of cancer cells. In fact, a plethora of previous
studies has reported that CXCL2 and CXCL3 stimulated the
proliferation of cancer cells [42–44]. Microarray and real-time PCR
results from our previous research, which showed that the expression
of CXCL2 and CXCL3 was increased in co-cultured CAFs, could
support our assumption. Moreover, regarding the increased tumor
volume of CAF-OSCC co-injected groups in a xenograft study, the
angiogenic effect of cytokines such as IL-1α and IL-8 might also have
contributed to the growth of tumors [45–48].
Here, we attempted to investigate reciprocal reaction between
cancer cells and CAFs regulated by cytokines: IL-1α, released from
carcinoma, stimulated CAFs resulting in the proliferation of CAFs
and the simultaneous increase of cytokine secretion promoted in the
proliferation of OSCC cells. Further research is needed to examine
autocrine effect of cytokines released from CAFs or OSCC cells that
might be also involved in cancer progression. This study unraveled
one of the mechanisms underlying the interaction between carcinoma
and CAFs, especially confined to IL-1α–secreting cancer. Further
study to elucidate the crosstalk between cancer cells and CAFs may
provide a new insight for the development of effective diagnostics and
therapeutics to treat OSCC and other types of cancers.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neo.2014.09.003.
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